Demand, Supply-Chain and Business Continuity Risks Arising from the Spread of COVID-19
First written in FY2020. 13 of 16 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2025DroppedAnnual reportThe business and other risks for the current fiscal year do not identify COVID-19 as a separate risk.
- FY2024-Q3RestatedAnnual report
「During the cumulative third-quarter period, no new business or other risks arose. In addition, there were no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It states that there are no new business and other risks and no material changes in business and other risks from the previous fiscal year. - FY2024-Q2RestatedAnnual report
「During the cumulative second-quarter period, no new business or other risks arose. In addition, there were no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It states that there are no new business and other risks and no material changes in business and other risks from the previous fiscal year. - FY2024-Q1RestatedAnnual report
「During the cumulative first-quarter period, no new business or other risks arose. In addition, there were no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It states that there are no new business and other risks and no material changes in business and other risks from the previous fiscal year. - FY2023-Q3RestatedAnnual report
「During the cumulative third-quarter period, no new business or other risks arose. In addition, there were no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It states that there are no new business and other risks and no material changes from the previous fiscal year. Caution regarding the infectious disease continues to be mentioned in the analysis of operating results. - FY2023-Q2RestatedAnnual report
「During the cumulative second-quarter period, no new business or other risks arose. In addition, there were no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
It states that there are no new business and other risks and no material changes from the previous fiscal year. In its analysis of operating results, it explains that caution regarding COVID-19 cannot be dispelled. - FY2023-Q1RestatedAnnual report
「As the number of people infected with COVID-19 remained subdued, the overall economy remained firm. However, caution regarding the spread of COVID-19 could not be dispelled.」
While the number of infections remained subdued and the economic environment showed resilience, caution regarding a further spread of infections continues. - FY2022RestatedAnnual report
「Although the fine chemicals industry to which the company belongs entered a gradual recovery trend from the impact of COVID-19, production and sales may be affected by various factors, including disruptions to logistics networks caused by the emergence of variant viruses and other factors, the closure of business sites due to employee infections, and the resulting paralysis of sales, production, engineering and administrative operations.」
Although it states that the business has moved into a gradual recovery trend from the impact of the infectious disease, it continues to identify risks to production and sales arising from variant viruses, disruptions to logistics networks, the closure of business sites and other factors. - FY2022-Q3RestatedAnnual report
「However, infections once again spread rapidly toward year-end due to a new variant virus, and the outlook for the economy remains fluid.」
Regarding the economic environment affected by the infectious disease, a recovery trend supported by vaccinations has emerged, while another spread caused by a new variant virus and uncertainty over demand and supply arrangements continue. - FY2022-Q2RestatedAnnual report
「During the six-month period under review, the global economy continued to recover, although there was a phase in which infections rose rapidly because of the spread of COVID-19 variants. This was against the backdrop of lower case numbers and a reduced risk of severe illness as vaccinations progressed. However, concern over another wave of infections remained strong, and economic conditions continued to be fluid.」
While indicating a recovery trend from the impact of the infectious disease, the company continues to caution against another spread of infections caused by variant viruses and notes ongoing uncertainty regarding demand, supply arrangements and other factors. It states that there were no material changes in business and other risks. - FY2022-Q1RestatedAnnual report
「However, caution regarding a further spread of infections remains strong due to the prevalence of variant viruses and other factors, and the outlook for the economy remains fluid.」
While the explanation has shifted to describe a recovery trend from the impact of the infectious disease, uncertainty surrounding the spread of variant viruses and demand and supply arrangements continues. It states that there were no material changes in business and other risks. - FY2021RestatedAnnual report
「Although the fine chemicals industry to which the company belongs is gradually emerging from the impact of COVID-19, production and sales may be affected by various factors, including declining demand and uncertainty over supply arrangements arising from the emergence of variant viruses and delays in the rollout of vaccinations, the closure of business sites due to employee infections, and the resulting paralysis of sales, production, engineering and administrative operations.」
Although the industry is gradually recovering from the impact of the infectious disease, the company continues to describe risks including variant viruses, delays in vaccination, declining demand, uncertainty over supply arrangements and the closure of business sites. It has also added system modification costs to accommodate new lifestyles and changes to personnel management methods as factors that may have an impact. - FY2021-Q3RestatedAnnual report
「During the nine-month period under review, the global economy showed signs of a gradual recovery after slowing significantly because of the impact of COVID-19, but concern intensified as infections began to spread again toward year-end.」
Although signs of recovery emerged after the economic slowdown caused by the infectious disease, infections spread again toward year-end, and caution regarding demand and the business environment continues. It states that there were no material changes in business and other risks. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter, the global economy was forced to slow significantly as the spread of COVID-19 continued, and subsequently recovered at an extremely gradual pace, but had not yet emerged from stagnation.」
It explains that the economic slowdown caused by the spread of the infectious disease continued, while the recovery was extremely gradual and the economy had not emerged from stagnation. It states that there were no material changes in business and other risks. - FY2021-Q1WorsenedAnnual report
「During the cumulative first quarter, the global economy was forced to slow significantly as economic activity was constrained by the spread of COVID-19.」
Restrictions on economic activity associated with the spread of the infectious disease continued to manifest as an actual economic slowdown, and the company's consolidated sales decreased 15.6% year on year. However, the notes on accounting estimates also state that the impact of the infectious disease has yet to emerge. - FY2020First statedAnnual report
「In addition to a sharp decline in demand accompanying the economic deterioration caused by the spread of COVID-19, production and sales may be affected by various factors, including supply chain disruptions due to travel restrictions, the closure of business sites due to employee infections, and the resulting paralysis of sales, production, engineering and administrative operations.」
Regarding the spread of the infectious disease, the company specifically identifies the sharp decline in demand, supply chain disruptions due to travel restrictions, the closure of business sites due to employee infections, and the paralysis of sales, production and other operations as separate risks. It also explains that, at this stage, no major impact on business performance has yet clearly emerged.